These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8203037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
    Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.
    Arnett DK, Jacobs DR, Luepker RV, Blackburn H, Armstrong C, Claas SA.
    Circulation; 2005 Dec 20; 112(25):3884-91. PubMed ID: 16344385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A, Aguilar-Salinas CA.
    Gac Med Mex; 1998 Dec 20; 134(2):253-6. PubMed ID: 9619005
    [No Abstract] [Full Text] [Related]

  • 10. [Decisions regarding cholesterol-lowering therapy in the elderly: the experience in a lipid clinic and a review of the literature].
    Garrido Sanjuán JA, Pía Iglesias G, González Moraleja J, Sesma P.
    An Med Interna; 1998 Jun 20; 15(6):305-10. PubMed ID: 9656510
    [Abstract] [Full Text] [Related]

  • 11. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN, Poliakova ED, Olfer'ev AM, Perova NV.
    Biull Eksp Biol Med; 1998 May 20; 125(5):569-73. PubMed ID: 9644562
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hypercholesterolemia: when and how much to treat it?].
    Carmena R.
    Med Clin (Barc); 1983 Feb 26; 80(6):261-2. PubMed ID: 6865558
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treating hypercholesterolemia and hypertension based on lifetime global risk.
    Kostis JB.
    Am J Cardiol; 2007 Jul 01; 100(1):138-42. PubMed ID: 17599456
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M, Rohmer V, Farnier M, Issa-Sayegh M, Corda C, Sirugue I, Gerlinger C, Masseyeff-Elbaz MF.
    Diabetes Metab; 2000 May 01; 26(3):184-91. PubMed ID: 10880891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.